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Background: Birch pollen allergic patients frequently experience gastrointestinal upset accompanied by a local
allergic inflammation in the small intestine especially during the pollen season. However, it is not known if the GI
pathology is connected to the subjective symptoms of the patient. The objective of this study was to evaluate the
immune pathology of the duodenal mucosa and the serum IgE antibody profiles in birch pollen allergic patients in
relation to their gastrointestinal symptoms, during and outside the birch pollen season.
Methods: Thirty-two patients with birch pollen allergy and sixteen healthy controls were enrolled in the study.
Twenty allergic patients had gastrointestinal symptoms and twelve did not. All participants underwent an allergy
investigation and gastroscopy with duodenal biopsy. The duodenal biopsies were retrieved during the pollen
season (May-June) and off-season (November-March). The biopsies were immunostained for mast cells (IgE and
tryptase), eosinophils, T cells (CD3), and dendritic cells (CD11c). Pollen-specific IgE antibodies were determined by
ImmunoCAP and component microarray (ISAC).
Results: Patients in both pollen allergic groups showed similar degree of intestinal allergic inflammation during the
pollen season regardless of gastrointestinal symptoms. The eosinophils, mast cells and dendritic cells were
increased in the mucosa. Patients with gastrointestinal symptoms had significantly elevated IgE antibodies to birch
(rBet v 1), hazelnut (rCor a 1), and apple (rMal d1) during the pollen season.
Conclusions: Patients allergic to birch pollen have clear signs of an ongoing allergic inflammation in their intestinal
mucosa, which is aggravated during the pollen season. The magnitude of the allergic intestinal inflammation is not
associated with subjective gastrointestinal symptoms of the individual patient.
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componentsBackground
Patients allergic to pollen may in addition to their
respiratory symptoms also experience gastrointestinal
disturbances, particularly during the pollen season. We
have previously reported that there are clear histological
signs of an ongoing allergic gastrointestinal inflammation
in birch pollen allergic patients who have gastrointestinal* Correspondence: grentzos@gmail.com
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unless otherwise stated.symptoms during the birch pollen season [1]. The patho-
physiological mechanisms underlying this type of allergic
reaction is still obscure [2-4], and it is unclear whether the
gastrointestinal symptoms are connected to the intestinal
inflammation.
The nature of the gastrointestinal (GI) symptoms in
pollen allergic patients varies. Some patients experience
gastrointestinal symptoms only during the pollen season
while others have continuous symptoms that aggravate
during the pollen season. Probably some of the latter
patients are diagnosed with irritable bowel syndromel Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Demographic data, and sensitization frequency
to inhalant allergens
S (n = 20) NS (n = 12) C (n = 16)
Men 10 7 5
Women 10 5 11





Animal dander 11 3
Dust mites 5 2
IgE-reactivity (median)
Total IgE 60.00 kU/L 58.00 kU/L 15.00 kU/L
IgE birch 6.14 kU/L 3.90 kU/L 0.00 kU/L
IgE grass 3.20 kU/L 3.65 kU/L 0.00 kU/L
IgE mugwort 0.05 kU/L 0.20 kU/L 0.00 kU/L
Median IgE values for pollen allergens and total IgE in the subjects included in
the study are depicted. NS = no gastrointenstinal symptoms, S = with
gastrointenstinal symptoms, C = healthy controls).
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ongoing inflammation in the duodenal mucosa in atopic
IBS patients that is not seen in non-atopic IBS patients
[5-7]. Interestingly, many patients with eosinophilic
esophagitis were diagnosed during the pollen season
[8-10]. Whether the pollen exposure by itself or rather
the ingestion of birch-pollen related food has an impact
on the gastrointestinal inflammation is not known.
An association between increased intestinal permeability
and severe bronchial hyperreactivity or asthma has been in-
dicated [11,12]. Patients with asthma or atopy without any
GI symptoms showed an increase of inflammatory media-
tors (IL-3, IL-5, GM-CSF), in the expanded populations of
eosinophils and mast cells seen in the duodenal biopsies
[13]. Furthermore, in children, a relation between allergy to
foods and severity of asthma has been demonstrated [14],
and asthmatic patients may experience life threatening
exacerbation when allergy to different foods co- exists [15].
A possible connection between the gastrointestinal
symptoms and IgE sensitization profile can be monitored
by a relatively new diagnostic tool, the allergen microarray
chip ISAC (Thermo Fisher/Phadia). This test allows profil-
ing of IgE reactivity to well defined allergen components
from different sources, which enables a more precise
monitoring of the IgE sensitization pattern to food allergen
components that are related to birch- pollen [16,17].
The aim of this study was to explore the immune
pathology of the duodenal mucosa in birch pollen allergic
patients, with or without GI symptoms, outside and
during the birch pollen season. In addition, we aimed to
relate these findings to the IgE antibody profile against
birch related food allergen components in these patients.
The results may add to the understanding of the etiology
of GI symptoms in pollen allergic patients.
Materials and methods
Study population
Patients and healthy controls were recruited from the
Asthma and Allergy clinic at the Sahlgrenska University
Hospital in Gothenburg, Sweden. The patients were
requested to answer a detailed questionnaire about their
birch pollen related symptoms and if and when they had
gastrointestinal symptoms (supplement attached).
All patients included were between 18–50 years old
and allergic to birch pollen. Some of the patients were
also allergic to other allergens (Table 1), and some were
diagnosed with oral allergy syndrome (OAS) and/or
asthma (Table 2). The diagnosis of birch-pollen allergy
was confirmed by a history of rhinoconjuctivitis and a
positive skin prick test for birch pollen. In total 60 subjects
were recruited to the study, twenty in each group. There
were 12 drop-outs, mainly due to discomfort during
the gastroscopy, and 48 subjects remained in the study.
Patients in the first group (S) (n = 20) were allergic tobirch pollen and had gastrointestinal symptoms during
the pollen. Patients in the second group (NS) (n = 12)
were also allergic to birch pollen but had no gastrointes-
tinal symptoms during the pollen season. The third group
(C) (n = 16) included healthy non-allergic individuals with
negative skin-prck test (SPT) and IgE-tests for inhalation
allergens, and served as controls (Figure 1). Exclusion cri-
teria for all subjects were confirmed inflammatory bowel
disease, celiac disease (none of the subjects were positive for
transglutaminase or gliadin antibodies in serum) or other
gastroenterological disease, food allergy to staple foods
(egg-white, milk, wheat, soy, peanut, codfish), pregnancy,
lactation, rheumatic or systemic disease, immune deficiency,
previous or current treatment with immunotherapy. The
gastroscopies were performed only as part of the present
study. All gastroscopies were executed by experienced
gastroenterologists, and no signs of macroscopic pathology
or abnormality were found neither in the esophageal nor in
the gastric or duodenal mucosa in any of the patients.
The demographic and clinical characteristics of the
patients and controls are shown in Table 1.
All allergic patients were under intermittent medication
with anti-histamines, nasal steroids and eye-drops during
the pollen-season. Patients with asthma used inhaled
corticosteroids and beta-mimetics when required. None of
the patients needed medication with oral or injected
corticosteroids.
The study was approved by the Ethics Committee of
Regional Ethical Review Board in Gothenburg with Dnr.
452–06. Written Informed consent was obtained from
the subjects.
Table 2 The number of patients with asthma and OAS
(oral allergy syndrome) and the frequency of the most
frequent gastrointestinal symptoms
S (n = 20) NS (n = 12)
Asthma 11 3
OAS 12 6
Gastrointestinal symptoms S (n = 20)
Pollen season-related symptoms 10
Symptoms all the time 10






Pain in the lower bowel 28
Bowel cramps 28
Pain relief with defecation 22
Burning sensation in esophagus 22
Nausea 11
Pain related to meal 11
Median IgE values for pollen allergens and total IgE in the subjects included in
the study are depicted. NS = no gastrointenstinal symptoms, S = with
gastrointenstinal symptoms, C = healthy controls).
Rentzos et al. Clinical and Translational Allergy 2014, 4:19 Page 3 of 11
http://www.ctajournal.com/content/4/1/19Allergy assessment
ImmunoCAP
The serum levels of total IgE and IgE antibodies to a
mix of common food allergens (fx5; egg-white, milk,
wheat, soy, peanut, codfish) and pollen allergens (birch,Figure 1 Overview of the selected study populations.grass, mugwort) were measured using ImmunoCAP
(Thermo Fisher/Phadia, Uppsala, Sweden) according to
the manufacturer’s instructions.
ISAC
Blood samples were collected during the pollen season
(5th May until 10th June) and outside the birch pollen
season (1st October until 5th March) for the determination
of IgE against allergen components using the allergen
microarray immunoassay, ImmunoCAP ISAC (Thermo
Fisher/Phadia) on which 103 allergen components are
spotted. Analysis included reactivity to the major Birch
allergens and the rest of PR-10 group of proteins, and the
major allergen from Timothy rPhl p 1. The results are
expressed as ISAC Standardized Units (ISU) with a
threshold of ≥0.3 ISU. The ISAC analysis was performed
as recommended by the manufacturer. The analysis of the
data was focused on the PR-10 proteins and birch- related
foods and a mean sensitization score was used.
All analyses except ISAC were performed at the
Laboratory of Clinical Biochemistry, Sahlgrenska University
Hospital, Gothenburg. The ISAC analyses were carried out
at the Department of Clinical Immunology, Karolinska
University Hospital, Stockholm, Sweden.
Gastroscopy and duodenal biopsies
Gastroscopies and duodenal biopsy sampling were
performed by gastroenterologist at the Department of
Endoscopy in the gastroenterology clinic, Sahlgrenska
University Hospital during the pollen season between the
5th of May until 5th of June, and outside the pollen season
between 1st November and 5th of March. The patients had
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before the gastroscopy. Gastroscopies were performed
with Olympus GIF Q160, Q180 or Fujinon 450 WR5
endoscopes. Biopsy specimens (6–7 specimens 2 to 3 mm
in size) from the descending part of the duodenum were
obtained. The tissue specimens were immediately embed-
ded in O.C.T. (Optimal Cutting Temperature) compound
(Tissue-Tek Miles, Inc, Elkhart, In, USA), frozen in iso-
pentane precooled by liquid nitrogen, and finally trans-
ferred into liquid nitrogen. The biopsy specimens and sera
were kept at −70°C until analyzed. All gastroscopies were
performed during three consecutive years 2008–2010.
Immunohistochemistry
Cryostat sections (7 μm) were stained as previously
described [18,19]. The slides were coded and evaluated in a
random order. All sections, except the ones detecting
eosinophilic endogenous peroxidase, were blocked by
the glucose oxidase sodium azide method to quench
endogenous peroxidase activity [20]. Eosinophilic en-
dogenous peroxidase was detected by just adding
AEC-substrate.Mouse monoclonal antibodies with the
following specificities were used: IgE (CIA-E-7.12,
IgG1 κ, DAKO, Stockholm, Sweden), CD3 (UCHT1,
IgG1 κ, SIGMA, St Louis, Mo, USA), mast cells tryptase
(EC 3.4.21.59 Clone AA1, DacoCytomation, Glostrup,
Denmark ) and CD11c purified (Integrin alpha X, p150/95,
leu M5 alpha Clone 3.9 eBioscience, San Diego, Ca, USA).
As a secondary antibody biotinylated horse anti-mouse IgG
(H+ L) (BA-2000, Vector Laboratories, Burlingame, Ca,
USA) was used followed by an avidin-biotin-peroxidase
enzyme complex (Vectastain ABC elite, Vector, UK). The
slides were developed by adding AEC substrate and counter
stained with Mayer’s Hematoxylin. Positively stained cells
were counted by using a computer supported image
analysis system Leica Q500MC (Leica, Cambridge,
United Kingdom). Cells in at least five 200 × fields
from the villi and the basal lamina propria regions of
the mucosa were counted by a blinded observer. The
IgE, CD3 and tryptase positive cells were recorded as
the number of stained cells/mm2 of tissue. The density
of CD11c + dendritic cells was estimated as the relative
stained area in at least five 100 × fields and expressed as
percent stained tissue area.
Statistics
The values represent individual data points or means and
median values. The statistical analyses were carried out by
using SPSS Statistics 17.0. Data are reported as medians
with interquartile ranges (IQR), and Mann–Whitney
U-tests were used for statistical comparison between
groups of patients. Data for each individual on cell
counts in biopsies and IgE reactivity between the seasons
was compared by Wilcoxon signed rank test. Correlationsbetween different parameters within the same group were
evaluated by Spearman’s correlation coefficient or, after
log-transformation, with Pearson’s correlation coefficient.
All tests were two-tailed and the level of significance was
set to P < 0.05.
Results
Questionnaire
Half of the S-patients (n = 10) reported symptoms only
during the pollen season while the rest had subjective
symptoms without any seasonal variation. Only one
patient experienced worsening of symptoms when
ingesting birch pollen-related foods. The most frequent
symptoms were: abdominal distension (73%) gases (72%),
stomach pain (44%), diarrhea (44%), constipation (33%).
Clinical and demographic characteristics of the subjects
are shown in Table 2. There were no significant differences
in the frequency and severity of symptoms that could be
related to the severity of the pollen seasons. The data
concerning the pollen counts between 2007–2010 are
provided in the Additional file 1: Figure S1.
Immunohistochemical parameters of duodenal mucosal
Allergic inflammation in the duodenal mucosa in birch
pollen allergic patients compared to healthy controls
The numbers of IgE-positive cells, eosinophils, tryptase-
positive cells and CD11c + dendritic cells were significantly
higher in S-patients compared with controls in the biopsies
taken during the pollen season. However, outside the pollen
season only IgE-positive cells and eosinophils were signifi-
cantly higher in the S-patients. In the NS-patients the
biopsies taken during the pollen season showed significantly
elevated number of IgE-positive cells, eosinophils, CD3+ T
cells, tryptase- positive cells and CD11c + dendritic cells as
compared with the controls. In this group only IgE-positive
cells and CD11c + dendritic cells remained elevated outside
the pollen season (Figure 2).
Intestinal allergic inflammation in birch pollen allergic
patients with or without GI symptoms
There was no significant difference in the duodenal
cell counts (mast cells, eosinophils, T cells, and
CD11c + dendritic cells) between the patient group with
gastrointestinal symptoms (S) as compared to patient
group without GI symptoms (NS). This was true both for
samples taken during and outside the pollen season
(Figure 3).
Seasonal variation in duodenal allergic inflammation
Patients with gastrointestinal symptoms (S-group)
During the birch pollen season there were significantly
higher numbers of IgE-positive cells (median: 212 cells/mm2)
(p = 0.049), CD3+ T cells (median: 954.50 cells/mm2)
(p = 0.040) and CD11c + dendritic cells (median: 2.9% of
Figure 2 The frequency (median and 95% confidence interval) of immune cells in the duodenal mucosa in the different patient groups
as indicated on the x axis (C = healthy controls, NS = patients without GI symptoms, S = patients with GI symptoms). The filled bars
represent biopsies taken outside the birch pollen season and the striped bars during the birch pollen season.
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toms than in the same patients outside the pollen season.
(Figure 4). However, there was no difference between
patients who experienced pollen season related gastro-
intestinal symptoms (n = 10) compared to patients with
symptoms not related to season (n = 10) in the S-
group. There was a correlation between the totalserum IgE and IgE-positive cells in the biopsies taken
during the pollen season (r = 0.540, p = 0.014). In
contrast, there was no correlation between the duo-
denal cell counts and the total number of symptoms
regardless of season. Furthermore, patients with oral
allergy syndrome (OAS), showed similar cell counts
during and outside the pollen season (not shown),
O:  outside pollen season
S:   pollen season
Figure 3 Seasonal variation in the duodenal cell count (median cell count per mm2 and 95% confidence interval) in patients with (S) or
without (NS) gastrointestinal symptoms. The filled bars represent biopsies taken outside the birch pollen season and the striped bars during the
birch pollen season.
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(p = 0.017) (median: 151 cells/mm2) in the duodenal
mucosa during the pollen season (not shown).
Patients without gastrointestinal symptoms (NS-group)
Also, in the NS-group, the duodenal biopsies showed
significantly higher numbers of CD11c + dendritic cells
(median: 3.55% of relative stained area) (p = 0.06) and
a tendency for elevated eosinophil counts (p = 0.050)
(median: 151.50 cells/mm2) and IgE-positive cells (p = 0.060)
(median: 241 cells/mm2) during the pollen season as
compared with the biopsy specimens taken off-season
(Figure 4). In this group there was a correlation between
total serum IgE and the number of IgE-positive cells
in the biopsies taken outside the pollen season (r = 0.660,
p = 0.020), but no significant correlation was found in
the biopsies taken during the pollen season.In the subgroup of patients with OAS there was an
elevated frequency of duodenal tryptase positive cells
(p = 0.037) (median: 120.50 cells/mm2) outside the pollen
season (not shown). Only three patients in the NS group
had asthma, which impaired further statistical analysis.
Intestinal allergic inflammation in asthmatics and
non-asthmatics
When examining the whole material including patients
from both S- and NS-group, no significant differences
could be seen in the duodenal cell populations when
comparing patients with or without asthma, regardless
of season.
Healthy controls
In the healthy controls, there were no seasonal changes
in any of the duodenal cell populations apart from the T
Figure 4 Seasonal variation in the duodenal cell count in individual patients of the different study populations. (C = healthy controls,
NS = patients without GI symptoms, S = patients with GI symptoms). Each colored line represents one patient and the left value is from outside
the birch pollen season and the value to the right from samples taken during the birch pollen season.
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the pollen season (p = 0.034) (Figure 4.)
IgE reactivity against allergen components
To compare the total IgE reactivity between the S- and
NS-group the sum of the ISU score for all PR-10
proteins from each patients was calculated in order to
obtain a mean score for each group. The overall mean
score of IgE reactivity to PR-10 proteins was significantly
higher (p < 0.001) in the S-group 62.91 ISU (IQR 65.30;
95% CI 20.90-104.90) compared to NS-group 0.12 ISU
(IQR 0.0; 95% CI −0.15-0.40). However, there were no
significant differences in the IgE levels against the PR-10
proteins between the S and NS groups when analyzing
the data separately for the different seasons. There was a
trend towards an elevated median sensitization score
in the S group to birch pollen related food 4.9 ISUFigure 5 Seasonal variation in IgE titers (ISU) to the major birch allerg
represents one patient and the left value is from outside the birch pollen s
pollen season (S= patients with GI symptoms, NS= patients without GI sym(IQR 15.9; 95% CI 2.11-29.86) compared to NS group
2.75 ISU (IQR 9.65; 95% CI −0.5-18.5) in samples
taken during the birch pollen season. The ISAC data
with the sensitization patterns of the patients are
shown in the Additional file 1: Table S1.
Patients with GI symptoms (S-group)
In this group we noted significantly higher levels of IgE
to the major birch pollen allergen (rBet v 1) (p = 0.047),
hazel pollen (rCor a 1.0101) (p = 0.014), and apple
(rMal d 1) (p = 0.041) in blood samples taken during
the birch pollen season. Outside the birch pollen season
there was an elevated IgE reactivity to timothy pollen rPhl
p 1 (p = 0.016) (Figure 5).
There were no significant differences in the IgE reactiv-
ity to any other ISAC component regardless of pollen
season. In the subgroup of patients with OAS thereen rBetv 1 and the grass pollen antigen Phlp1. Each colored line
eason and the value to the right from samples taken during the birch
ptoms).
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antigens both during and outside the pollen season
for rBet v 1 (p = 0.020, resp p = 0.006) and rAln g 1
(alder) (p = 0.010, resp p = 0.002), as well as to the
related food antigens, rMal d 1 (p = 0.044, resp p = 0.029),
rPru p 1 (peach) (p = 0.002, resp p = 0.002), rAra h 8
(peanut) (p = 0.014, resp p = 0.022), rCor a 1.04 (hazelnut)
(p = 0.012, resp p = 0.004).
In this group the median average IgE reactivity to all
PR-10 proteins was 21 ISU (IQR 33; 95% CI 9.42-64.08),
and to birch- related foods 4.9 ISU (IQR 15.9; 95% CI
2.11-29.86) in samples taken during the pollen season,
compared with 11 ISU (IQR 46.2; 95% CI 10.11-42.21)
and 2.9 ISU (IQR 15; 95% CI 3.48-18.33) respectively, in
samples taken off-season. The results concerning the
mean score of ISAC components are provided in the
Additional file 1: Table S1. The IgE reactivity to PR-10
proteins in the serum samples correlated significantly
with the numbers of eosinophils in biopsies taken during
the pollen season and with the total IgE levels in serum both
during and outside the pollen season (r = 0.63 p = 0.004 and
r = 0.67, p = 0.002 respectively). A positive correlation was
also found between CD11c + cells in biopsies taken during
the pollen season and IgE for rCor a 1.0101 (r = 0.61
p = 0.006) and rAra h 8 (r = 0.50 p = 0.028).
There was no correlation between IgE reactivity to
components of the PR-10 proteins and the symptoms
displayed by each patient neither during nor outside the
pollen season.
Patients without GI symptoms (NS-group)
In asymptomatic patients there was no correlation between
the degree of intestinal inflammation and the reactivity to
PR-10 proteins. In this group of patients there was a
significantly higher IgE reactivity to grass pollen rPhl
p 1 (p = 0.010) and rMal d 1 (p = 0.018) in blood
samples taken during the birch pollen season and in rAln g
1 (p = 0.002), nAct d 8 (p = 0.018) and rGly m 4 (p = 0.017)
in samples taken outside the birch pollen season. In the
subgroup of OAS patients we found a significantly elevated
IgE reactivity to some pollen and pollen related com-
ponents like rCor a 1.0101 (p = 0.022), rPru p 1, rAra
h 8 (p = 0.036) in samples taken during the pollen
season, and to rCor a 1.0101 (p = 0.013), to rPru p
1(p = 0.037) as well as r Ara h 8 (p = 0.020) in samples
taken off-season. The median of average IgE reactivity to all
PR-10 proteins was 18.9 ISU (IQR 65.18; 95% CI 3.6-89.7),
and to birch-related foods 2.75 ISU (IQR 9.65; 95%
CI −0.5-18.5) in samples taken during the birch pollen sea-
son, compared to 9.65 ISU (IQR 39.75; 95% CI 1.9-49.5)
and 2.8 ISU (IQR 7.15; 95% CI −0.62-14.8), respectively, in
samples taken outside the pollen season. The results
showing the mean score of ISAC components are
provided in the Additional file 1: Table S1.Healthy controls
None of the healthy controls showed IgE reactivity to
any of the allergens tested.
Discussion
The objective of this study was to elucidate whether sub-
jective gastrointestinal symptoms in birch pollen allergic
patients are related to the degree of allergic inflammation
in their intestinal mucosa, and to monitor if the intestinal
allergic inflammation varies with the pollen season. Pollen
allergic patients with gastrointestinal symptoms were
compared with birch pollen allergic patients without any
subjective and self-reported gastrointestinal disturbances
and both these groups were compared with a group of
healthy individuals. The results show that birch-pollen
allergic patients with gastrointestinal symptoms, display a
significant intestinal allergic inflammation with elevated
numbers of eosinophils, IgE-positive cells, CD3+ T cells
and CD11c + dendritic cells during the pollen season. This
confirmed our previous findings [1]. The design of the
present study with a larger patient sample than the previous
study, allowed us to discriminate between patients with or
without subjective GI symptoms and revealed that the
intestinal allergic inflammation was obvious also in asymp-
tomatic patients Also in these patients the pathology was
aggravated during the birch pollen season. Furthermore, in
both patients with and without GI symptoms, we observed
elevated levels of IgE to most of the PR10-proteins during
the pollen season. This was particularly pronounced in
patients with OAS, indicating that cross reactions to birch
related food may play a role in their pathology, which is
supported by the “trigger foods” causing GI symptoms in
OAS [21]. In addition, we observed that patients with
allergic asthma were more prone to duodenal allergic
inflammation as compared with non-asthmatic patients.
The reason for this is unclear but could be due to a more
severe allergy with greater engagement of the common
mucosal immune system.
An elevated production of IgE antibodies against pollen
allergens [22] during the birch pollen season is well estab-
lished, but there are very few studies exploring the
sensitization pattern to birch pollen related foods in rela-
tion to the birch pollen season [16]. Interestingly, high
prevalence of clinical reactions to fruits and vegetables has
been shown in birch pollen-sensitized patients with even
higher prevalence in multi pollen-sensitized patients,
which supports the notion that ingestion of pollen-related
foods may act as an eliciting factor for allergic symptoms
from different organs [23]. Reactivity to allergen compo-
nents may identify allergens sharing similar structures,
enabling detection of different levels of co-recognition by
allergen-specific IgE antibodies e.g. Bet v 1 homologous
allergens from hazelnut, apple and celery or vicilins from
different legume seeds [16,17,24]. We found that IgE levels
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pollen related food items, are clearly increased during the
birch pollen season in both groups of birch pollen allergic
patients. In addition we observed that the IgE levels
to some of the birch-pollen related foods like apple
and peach, but also peanut, were significantly higher in
patients with OAS. These findings support the hypothesis
that ingestion of food items that are related to birch pollen
might have a significant role in the allergic inflammation
of the intestinal mucosa [19,25]. This may suggest that
ingestion of birch pollen related food items during the
birch pollen season could precipitate the onset of the
gastrointestinal symptoms observed in pollen allergic
patients. In support of this a recent study by Pickert et al.
showed that 81% of patients with birch pollinosis and
GI-symptoms, display a wheal and flare reaction in
the gastrointestinal mucosa after colonoscopic allergen
provocation with Bet v 1. Interestingly, a similar mucosal
reaction was observed in 22% of birch pollen allergic
patients with pollinosis who did not experience any
GI-symptoms [26].
In the present study the patients in the S-group were
found to have a continuous intestinal eosinophilia not
related to the pollen season, which may indicate that they
react to ingested pollen related food. This is supported by
the positive correlation between eosinophil counts in
in-season biopsies and the IgE reactivity to the PR-10
proteins during the pollen season. It is interesting though
that birch-pollen allergic patients without gastrointestinal
symptoms have a significantly increased intestinal eosino-
philia during the pollen season. This may suggest a reaction
to the pollen itself rather than pollen related food items,
with a dissemination of the inflammation within the com-
mon mucosal immune system. A similar phenomenon has
been observed in patients with eosinophilic esophagitis,
where signs of a generalized subclinical eosinophilic inflam-
mation at mucosal sites were part of the pathology [27,28].
Eosinophilic infiltration of the esophageal mucosa in
patients with respiratory tract allergy has also been noted
during the period of pollen allergy symptoms [28].
A number of clinical studies suggest a possible link
between atopy and the augmentation of gastrointestinal
symptoms during the birch pollen season in patients
allergic to pollen [7,29,30], but few have addressed the
cause of these GI symptoms [26]. Interestingly, in the
present study the most frequent GI symptoms reported
were abdominal distension, gases, pain, diarrhea, and
constipation, which are common symptoms in patients
diagnosed with IBS. Mast cells have been proposed to be
included in the pathogenesis of IBS and increased num-
bers of mast cells have been found in intestinal mucosal
biopsies in patients with IBS [31-34]. In line with these
results we found a significantly higher number of IgE
positive as well as tryptase-positive cells in the group ofpatients with GI symptoms compared to controls. In
a more recent study examining both allergic and non-
allergic patients with IBS, there was a higher number
of eosinophils in the intestinal biopsies from patients
with both atopy and IBS [5]. These results indicate
that a number of patients with an allergic inflamma-
tion in the GI tract are diagnosed with IBS, which
may hinder a correct diagnosis of their illness.
One possible limitation in the present study is that the
patients were recruited during three consecutive years
with variable severity of the seasonal pollen exposure,
and that the individual natural exposure to pollen also
varies according to living habits. However, the birch
pollen seasons during the study years 2008–2010 were of
representative severity for the study area without extreme
variations (see supplement).
Conclusions
In conclusion, we show here that regardless of subjective
gastrointestinal symptoms, patients allergic to birch
pollen have clear signs of an ongoing allergic inflamma-
tion in their intestinal mucosa, which is aggravated during
the pollen season. Furthermore, patients who experience
GI symptoms show somewhat elevated IgE levels to PR-10
proteins compared to the asymptomatic patients, which
could be associated with the intake of birch pollen related
food items.
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Additional file 1: The questionnaire used for grading the symptoms
in the group of patients with gastrointestinal symptoms.
Abbreviations
S-group: Birch pollen allergic patients with gastrointestinal symptoms;
NS-group: Birch pollen allergic patients without gastrointestinal symptoms;
C-group: Control; CRD: Component-resolved diagnostic tests;
GI: Gastrointestinal; OAS: Oral allergy syndrome; ISU: ISAC standardized units;
SPT: Skin-prick test.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
All authors were involved in the discussions and contributed to writing the
document. All authors read and approved the final manuscript.
Acknowledgements
We thank Ass. Prof. Ulf Bengtsson Prof. Staffan Ahlstedt, and Prof. Marianne
van Hage for their important scientific contribution to this study and
additionally Prof. Marianne van Hage for performing the ISAC-analyses. We
want to thank especially our research nurse Åke Alfredsson (Department of
Respiratory Medicine and Allergology, Section of Allergology, Sahlgrenska
University Hospital) for excellent assistance in this study. We also thank the
staff at the Section of Allergology, and at the Section of Endoscopy, Department
of Gastroenterology and Hepatology, Department of Internal Medicine,
Sahlgrenska University Hospital.
This work was supported by grants from the Swedish Asthma and Allergy
Foundation, The Göteborg Medical Society, Konsul Th C Berghs Stiftelse,
Herman Krefting Research Centre.
Rentzos et al. Clinical and Translational Allergy 2014, 4:19 Page 11 of 11
http://www.ctajournal.com/content/4/1/19Author details
1Section of Allergology, Sahlgrenska University Hospital, Gothenburg 413 45,
Sweden. 2Department of Rheumatology and Inflammation Research,
Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
3Department of Internal Medicine, Section of Gastroenterology, Sahlgrenska
University Hospital, Gothenburg, Sweden.
Received: 29 April 2014 Accepted: 20 May 2014
Published: 30 May 2014References
1. Magnusson J, Lin XP, Dahlman-Hoglund A, Hanson LL, Telemo E, Magnusson O,
Bengtsson U, Ahlstedt S: Seasonal intestinal inflammation in patients with
birch pollen allergy. J Allergy Clin Immunol 2003, 112(1):45–50. Epub 2003/07/09.
2. Caffarelli C, Romanini E, Caruana P, Street ME, de’ Angelis G: Clinical food
hypersensitivity: the relevance of duodenal immunoglobulin E-positive
cells. Pediatr Res 1998, 44(4):485–490. Epub 1998/10/17.
3. Knutson TW, Bengtsson U, Dannaeus A, Ahlstedt S, Stalenheim G, Hallgren R,
Knutson L: Intestinal reactivity in allergic and nonallergic patients: an
approach to determine the complexity of the mucosal reaction. J Allergy
Clin Immunol 1993, 91(2):553–559. Epub 1993/02/01.
4. Thompson WG, Longstreth GF, Drossman DA, Heaton KW, Irvine EJ,
Muller-Lissner SA: Functional bowel disorders and functional abdominal
pain. Gut 1999, 45(Suppl 2):II43–II47. Epub 1999/08/24.
5. Lillestol K, Helgeland L, Arslan Lied G, Florvaag E, Valeur J, Lind R, Berstad A:
Indications of ‘atopic bowel’ in patients with self-reported food
hypersensitivity. Aliment Pharmacol Ther, 31(10):1112–1122.
Epub 2010/02/19.
6. Tobin MC, Keshavazian A, Farhardi A: Atopic irritable bowel syndrome:
same old hat or a new entity? Expert Rev Gastroenterol Hepatol 2008,
2(4):457–459. Epub 2008/12/17.
7. Tobin MC, Moparty B, Farhadi A, DeMeo MT, Bansal PJ, Keshavarzian A:
Atopic irritable bowel syndrome: a novel subgroup of irritable bowel
syndrome with allergic manifestations. Ann Allergy Asthma Immunol 2008,
100(1):49–53. Epub 2008/02/08.
8. Moawad FJ, Veerappan GR, Lake JM, Maydonovitch CL, Haymore BR, Kosisky SE,
Wong RK: Correlation between eosinophilic oesophagitis and aeroallergens.
Aliment Pharmacol Ther 2010, 31(4):509–515. Epub 2009/11/21.
9. Liacouras CA, Ruchelli E: Eosinophilic esophagitis. Curr Opin Pediatr 2004,
16(5):560–566. Epub 2004/09/16.
10. Liacouras CA: Eosinophilic esophagitis. Gastroenterol Clin North Am 2008,
37(4):989–998. xi. Epub 2008/11/26.
11. Benard A, Desreumeaux P, Huglo D, Hoorelbeke A, Tonnel AB, Wallaert B:
Increased intestinal permeability in bronchial asthma. J Allergy Clin
Immunol 1996, 97(6):1173–1178. Epub 1996/06/01.
12. Knutson TW, Bengtsson U, Dannaeus A, Ahlstedt S, Knutson L: Effects of
luminal antigen on intestinal albumin and hyaluronan permeability and
ion transport in atopic patients. J Allergy Clin Immunol 1996,
97(6):1225–1232. Epub 1996/06/01.
13. Wallaert B, Desreumaux P, Copin MC, Tillie I, Benard A, Colombel JF,
Gosselin B, Tonnel AB, Janin A: Immunoreactivity for interleukin 3 and 5 and
granulocyte/macrophage colony-stimulating factor of intestinal mucosa in
bronchial asthma. J Exp Med 1995, 182(6):1897–1904. Epub 1995/12/01.
14. Roberts G, Lack G: Food allergy and asthma–what is the link? Paediatr
Respir Rev 2003, 4(3):205–212. Epub 2003/07/26.
15. Roberts G, Patel N, Levi-Schaffer F, Habibi P, Lack G: Food allergy as a risk
factor for life-threatening asthma in childhood: a case-controlled study.
J Allergy Clin Immunol 2003, 112(1):168–174. Epub 2003/07/09.
16. Ebo DG, Bridts CH, Verweij MM, de Knop KJ, Hagendorens MM, de Clerck LS,
Stevens WJ: Sensitization profiles in birch pollen-allergic patients with
and without oral allergy syndrome to apple: lessons from multiplexed
component-resolved allergy diagnosis. Clin Exp Allergy 2010,
40(2):339–347. Epub 2009/08/28.
17. Wensing M, Akkerdaas JH, van Leeuwen WA, Stapel SO, Bruijnzeel-Koomen CA,
Aalberse RC, Bast BJ, Knulst AC, van Ree R: IgE to Bet v 1 and profilin:
cross-reactivity patterns and clinical relevance. J Allergy Clin Immunol 2002,
110(3):435–442. Epub 2002/09/05.
18. Dahlman-Hoglund A, Ahlstedt S, Hanson LA, Dahlgren U, Telemo E:
Different expression of IL-2 receptor alpha-chain on a lamina propria T
cell population and goblet cells in rats orally tolerized or sensitized toovalbumin (OA) after colonization with an OA-producing Escherichia coli.
Clin Exp Immunol 1996, 106(3):534–540. Epub 1996/12/01.
19. Lin XP, Magnusson J, Ahlstedt S, Dahlman-Hoglund A, Hanson LL, Magnusson O,
Bengtsson U, Telemo E: Local allergic reaction in food-hypersensitive adults
despite a lack of systemic food-specific IgE. J Allergy Clin Immunol 2002,
109(5):879–887. Epub 2002/05/08.
20. Andrew SM, Jasani B: An improved method for the inhibition of
endogenous peroxidase non-deleterious to lymphocyte surface markers.
Application to immunoperoxidase studies on eosinophil-rich tissue
preparations. Histochem J 1987, 19(8):426–430. Epub 1987/08/01.
21. Skypala IJ, Calderon MA, Leeds AR, Emery P, Till SJ, Durham SR:
Development and validation of a structured questionnaire for the
diagnosis of oral allergy syndrome in subjects with seasonal allergic
rhinitis during the UK birch pollen season. Clin Exp Allergy 2011,
41(7):1001–1011.
22. Ebner C, Hirschwehr R, Bauer L, Breiteneder H, Valenta R, Ebner H, Kraft D,
Scheiner O: Identification of allergens in fruits and vegetables: IgE
cross-reactivities with the important birch pollen allergens Bet v 1 and
Bet v 2 (birch profilin). J Allergy Clin Immunol 1995, 95(5 Pt 1):962–969.
Epub 1995/05/01.
23. Osterballe M, Hansen TK, Mortz CG, Bindslev-Jensen C: The clinical relevance
of sensitization to pollen-related fruits and vegetables in unselected
pollen-sensitized adults. Allergy 2005, 60(2):218–225. Epub 2005/01/14.
24. Fernandez-Rivas M, Bolhaar S, Gonzalez-Mancebo E, Asero R, van Leeuwen A,
Bohle B, Ma Y, Ebner C, Rigby N, Sancho AI, Miles S, Zuidmeer L, Knulst A,
Breiteneder H, Mills C, Hoffmann-Sommergruber K, van Ree R: Apple allergy
across Europe: how allergen sensitization profiles determine the clinical
expression of allergies to plant foods. J Allergy Clin Immunol 2006,
118(2):481–488. Epub 2006/08/08.
25. Powe DG, Bonnin AJ, Jones NS: ‘Entopy’: local allergy paradigm. Clin Exp
Allergy 2010, 40(7):987–997. Epub 2010/07/21.
26. Pickert CN, Lorentz A, Manns MP, Bischoff SC: Colonoscopic allergen
provocation test with rBet v 1 in patients with pollen-associated food
allergy. Allergy 2012, Epub 2012/08/24.
27. Almansa C, Krishna M, Buchner AM, Ghabril MS, Talley N, DeVault KR,
Wolfsen H, Raimondo M, Guarderas JC, Achem SR: Seasonal distribution in
newly diagnosed cases of eosinophilic esophagitis in adults. Am J
Gastroenterol 2009, 104(4):828–833. Epub 2009/02/26.
28. Onbasi K, Sin AZ, Doganavsargil B, Onder GF, Bor S, Sebik F: Eosinophil
infiltration of the oesophageal mucosa in patients with pollen allergy
during the season. Clin Exp Allergy 2005, 35(11):1423–1431. Epub 2005/11/22.
29. Simren M, Mansson A, Langkilde AM, Svedlund J, Abrahamsson H,
Bengtsson U, Bjornsson ES: Food-related gastrointestinal symptoms in the
irritable bowel syndrome. Digestion 2001, 63(2):108–115. Epub 2001/03/13.
30. Zar S, Kumar D, Benson MJ: Food hypersensitivity and irritable bowel
syndrome. Aliment Pharmacol Ther 2001, 15(4):439–449. Epub 2001/04/04.
31. Goral V, Kucukoner M, Buyukbayram H: Mast cells count and serum
cytokine levels in patients with irritable bowel syndrome.
Hepatogastroenterology 2010, 57(101):751–754. Epub 2010/11/03.
32. O’Sullivan M, Clayton N, Breslin NP, Harman I, Bountra C, McLaren A,
O’Morain CA: Increased mast cells in the irritable bowel syndrome.
Neurogastroenterol Motil 2000, 12(5):449–457. Epub 2000/09/30.
33. Santos J, Guilarte M, Alonso C, Malagelada JR: Pathogenesis of irritable
bowel syndrome: the mast cell connection. Scand J Gastroenterol 2005,
40(2):129–140. Epub 2005/03/15.
34. Barbara G, de Giorgio R, Stanghellini V, Cremon C, Salvioli B, Corinaldesi R:
New pathophysiological mechanisms in irritable bowel syndrome.
Aliment Pharmacol Ther 2004, 20(Suppl 2):1–9. Epub 2004/09/01.
doi:10.1186/2045-7022-4-19
Cite this article as: Rentzos et al.: Intestinal allergic inflammation in
birch pollen allergic patients in relation to pollen season, IgE
sensitization profile and gastrointestinal symptoms. Clinical and
Translational Allergy 2014 4:19.
